Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Nese Demirturk"'
Autor:
Elif Sargin Altunok, Murat Sayan, Sila Akhan, Bilgehan Aygen, Orhan Yildiz, Suda Tekin Koruk, Resit Mistik, Nese Demirturk, Onur Ural, Şükran Kose, Aynur Aynioglu, Fatime Korkmaz, Gülden Ersoz, Nazan Tuna, Celal Ayaz, Faruk Karakecili, Derya Keten, Dilara Inan, Saadet Yazici, Safiye Koculu, Taner Yildirmak
Publikováno v:
International Journal of Infectious Diseases, Vol 50, Iss C, Pp 1-5 (2016)
Background: Drug resistance development is an expected problem during treatment with protease inhibitors (PIs), this is largely due to the fact that Pls are low-genetic barrier drugs. Resistance-associated variants (RAVs) however may also occur natur
Externí odkaz:
https://doaj.org/article/746674f3f2674d80aa0bd064e45cced1
Autor:
Nese Demirturk, Tuna Demirdal
Publikováno v:
Clinical and Molecular Hepatology, Vol 20, Iss 1, Pp 56-60 (2014)
Background/AimsThe aims of the present study were to determine the outcomes of inactive hepatitis B virus (HBV) surface antigen (HBsAg) carriers over a 10-year study period and to elucidate the HBV serological profile of their family members.MethodsW
Externí odkaz:
https://doaj.org/article/c8306fba9c3e421e949787af1771e1a4
Autor:
Petek Konya, Nese Demirturk
Objective: The main purpose of chronic hepatitis B (CHB) treatment is to improve the patients’ life quality and prevent the disease from progressing to cirrhosis or hepatocellular carcinoma. Continuous suppression of hepatitis B virus (HBV) DNA wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::898036716c9514c754b952cce555e022
https://hdl.handle.net/20.500.12933/1363
https://hdl.handle.net/20.500.12933/1363
Autor:
Suda Tekin, Nese Demirturk
Şiddetli akut solunum sendromu virusu (SARS-CoV-2)’nun neden olduğu koronavirus hastalığı 2019 (COVID-19), 11 Mart 2020’de Dünya Sağlık Örgütü tarafından pandemi ilan edildikten sonra, kısa sürede büyük bir küresel sağlık tehdi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574d03302dc614131b5defc46f465779
https://hdl.handle.net/20.500.12933/1053
https://hdl.handle.net/20.500.12933/1053
Autor:
Havva Tunay, Nese Demirturk
Publikováno v:
Medicine Science | International Medical Journal. 11:1234
HCV infection is commonly asymptomatic, most people infected with HCV are not aware that they are infected, and most of those who receive a diagnosis also currently cannot reach treatment. Our study, it was aimed to appreciate the rate of anti-HCV-po
Publikováno v:
Osong Public Health and Research Perspectives, Vol 14, Iss 1, Pp 40-50 (2023)
Objectives We evaluated pain, fatigue, anxiety, depression, and quality of life in patients hospitalized for coronavirus disease 2019 (COVID-19) and observed them over a period of 3 months. We also investigated the relationship of these symptoms to a
Externí odkaz:
https://doaj.org/article/a36b242b651f4cfb85dd6b729f8f7afe
Autor:
Bilgehan Aygen, Derya Keten, Halis Akalin, Ali Asan, Heval Bozdag, Unal Cagir, Nese Demirturk, Haluk Eraksoy, Afet Erbay, Yunus Gurbuz, Dilara Inan, Safiye Koculu, Serkan Oncu, Deniz Ozkaya, Nese Saltoglu, Murat Sayan, Kaya Suer, Alper Sener, Suda Tekin Koruk, Nazan Tuna, Saadet Yazici
Publikováno v:
Klimik Dergisi/Klimik Journal. 27:19-39
Publikováno v:
Türkiye Parazitoloji Dergisi, Vol 46, Iss 3, Pp 224-227 (2022)
Objective:Crimean Congo Hemorrhagic Fever (CCHF); fever, widespread pain in the body, deterioration in liver function tests; it is a tick-borne viral infectious disease that can cause bleeding and death in the skin, mucous membranes, and sometimes in
Externí odkaz:
https://doaj.org/article/38546a7c328b423bb7e07db9f275eed6
Publikováno v:
The Southeast Asian journal of tropical medicine and public health. 44(6)
The aim of this study was to retrospectively investigate nosocomial bloodstream infections (NBI) and their antimicrobial susceptibility patterns at Afyon Kocatepe University (AKU) Hospital, Turkey, from January 2006 to December 2011 and to determine
Autor:
Nurullah Okumuş, Neşe Demirtürk, Rıza Aytaç Çetinkaya, Rahmet Güner, İsmail Yaşar Avcı, Semiha Orhan, Petek Konya, Bengü Şaylan, Ayşegül Karalezli, Levent Yamanel, Bircan Kayaaslan, Gülden Yılmaz, Ümit Savaşçı, Fatma Eser, Gürhan Taşkın
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background and objectives An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness in treatment
Externí odkaz:
https://doaj.org/article/5462c2a8a64b4f2690df4fb170b80248